Ulrik Cordes

Company: Cordes Biotech A/S

Job title: Founder & Chief Executive Officer

Seminars:

Next-Gen TIL Therapy With a Broader T-Cell Repertoire – The Key to Unlocking Less Immunogenic Solid Tumor Indications 2:30 pm

• Explore reinvigoration of exhausted TILs by ex vivo checkpoint blockade and stimulation generating a TIL product with a broader T-cell repertoire • Investigate reduction in required starting material to a few milligrams of tumor allowing for minimally invasive TIL therapy to expand patient reach • Examine T-cell repertoire breadth, depth and functionality – the…Read more

day: Day One